Pricing Log in Create free account

Cardio Diagnostics Holdings, Inc. (CDIO) vs Skye Bioscience, Inc. (SKYE)

Cardio Diagnostics Holdings, Inc. and Skye Bioscience, Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Skye Bioscience, Inc. are of similar size ($5.0M and $4.6M). Skye Bioscience, Inc. has the higher net margin (0.00% vs −42,429.2%) and the higher return on invested capital (0.00% vs −228.0%). Across the 14 metrics below, Cardio Diagnostics Holdings, Inc. leads on 7 and Skye Bioscience, Inc. on 7.

Valuation

Metric CDIO SKYE Biotechnology median
P/E n/m n/m 10.60
P/S 319.37 16.46 9.40
P/B 0.85 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 61.50 3.61 9.02
Earnings yield (176.97%) (1,026.26%) (32.88%)
Free cash flow yield (121.78%) (779.11%) (23.13%)

Profitability

Metric CDIO SKYE Biotechnology median
Gross margin 100.00% 68.04% 68.51%
Operating margin (42,356.17%) 0.00% 0.00%
Net margin (42,429.24%) 0.00% 0.00%
Free cash flow margin (37,817.51%) 0.00% 0.00%
Return on equity (93.55%) (233.87%) (51.96%)
Return on assets (87.24%) (159.80%) (46.06%)
Return on invested capital (227.98%) 0.00% 0.00%

Growth

Metric CDIO SKYE Biotechnology median
Revenue growth (TTM) (3.23%) — 6.76%
EPS growth (last fiscal year) 60.15% (93.15%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDIO SKYE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.44 0.95 4.97
Net debt to EBITDA 0.84 0.45 1.01

Dividend

Metric CDIO SKYE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CDIO SKYE Biotechnology median
Market cap 4.96m 4.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack